iuvo BioScience has named Christopher Houston, director of analytical chemistry. With sixteen years of analytical development experience in the pharmaceutical and medical device industries, Dr. Houston is an expert in the field of assessment of extractables and leachables for pharmaceuticals.

Prior to joining iuvo BioScience, Dr. Houston served as a senior analytical scientist at Bausch + Lomb where, among other accomplishments, he created and managed a successful extractables and leachables program. Dr. Houston also has held roles with increasing levels of responsibilities in analytical development at Pfizer and Pharmacia.

As director of analytical chemistry at iuvo BioScience, he will be responsible for expanding and growing that segment of iuvo’s laboratory testing offerings.

“We are absolutely thrilled to welcome Chris to the iuvo BioScience team,” said Mary Richardson, chief scientific officer and executive vice president, iuvo BioScience’s. “Chris is an incredibly meticulous scientist with a long record of superior performance and significant contributions. The depth of his expertise coupled with his leadership abilities will serve our clients’ needs extremely well, and help drive iuvo BioScience’s growth significantly.”